IMPLANT SITE EFFUSION side effect
What is IMPLANT SITE EFFUSION ?IMPLANT SITE EFFUSION : Zoladex Side Effects Report #5392463-2
Health Professional from UNITED STATES reported ZOLADEX problem on July 12, 2007. Female patient, 46 years of age, weighting 252.4 lb, was diagnosed with breast cancer and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: implant site effusion, . ZOLADEX dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, LASIX, POTASSIUM CHLORIDE, ALBUMIN, ARIMIDEX, VITAMIN B, TRIAMCINOLONE, CAMPHOR. Patient recovered.
IMPLANT SITE EFFUSION : Zoladex Side Effects Report #5392463-2
ZOLADEX problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Female patient, 46 years of age, weighting 252.4 lb, was diagnosed with breast cancer and was treated with ZOLADEX. After drug was administered, patient experienced the following problems/side effects: implant site effusion, . ZOLADEX dosage: unknown. During the same period patient was treated with SPIRONOLACTONE, LASIX, POTASSIUM CHLORIDE, ALBUMIN, ARIMIDEX, VITAMIN B, TRIAMCINOLONE, CAMPHOR. Patient recovered.
IMPLANT SITE EFFUSION : Bevacizumab Side Effects Report #5583764-3
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 03, 2008. Female patient, 37 years of age, was diagnosed with breast cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: feeling abnormal, implant site cellulitis, implant site effusion, malaise, pyrexia, . BEVACIZUMAB dosage: 600MG 2 WEEK SCHEDULE IV. Patient was hospitalized. Patient recovered.